Preclinical and post-treatment changes in the HCC-associated serum proteome

SELDI-based proteomic profiling of body fluids is currently in widespread use for cancer biomarker discovery. We have successfully used this technology for the diagnosis of hepatocellular carcinoma (HCC) in hepatitis C patients and now report its application to serial serum samples from 37 hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, D G, Cheng, Y, N'Kontchou, G, Thar, T T, Barget, N, Wei, W, Martin, A, Beaugrand, M, Johnson, P J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360589/
https://www.ncbi.nlm.nih.gov/pubmed/17060939
http://dx.doi.org/10.1038/sj.bjc.6603429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360589/
https://www.ncbi.nlm.nih.gov/pubmed/17060939
http://dx.doi.org/10.1038/sj.bjc.6603429

Ejemplares similares